199 related articles for article (PubMed ID: 10720426)
1. Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts.
Zimmerman D; Jin F; Leboy P; Hardy S; Damsky C
Dev Biol; 2000 Apr; 220(1):2-15. PubMed ID: 10720426
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
Dai XM; Zong XH; Akhter MP; Stanley ER
J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
[TBL] [Abstract][Full Text] [Related]
3. Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1.
Schiltz C; Prouillet C; Marty C; Merciris D; Collet C; de Vernejoul MC; Geoffroy V
J Cell Physiol; 2010 Jan; 222(1):219-29. PubMed ID: 19780057
[TBL] [Abstract][Full Text] [Related]
4. Skeletal phenotype of growing transgenic mice that express a function-perturbing form of beta1 integrin in osteoblasts.
Globus RK; Amblard D; Nishimura Y; Iwaniec UT; Kim JB; Almeida EA; Damsky CD; Wronski TJ; van der Meulen MC
Calcif Tissue Int; 2005 Jan; 76(1):39-49. PubMed ID: 15477996
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
[TBL] [Abstract][Full Text] [Related]
6. Effects of disrupted beta1-integrin function on the skeletal response to short-term hindlimb unloading in mice.
Iwaniec UT; Wronski TJ; Amblard D; Nishimura Y; van der Meulen MC; Wade CE; Bourgeois MA; Damsky CD; Globus RK
J Appl Physiol (1985); 2005 Feb; 98(2):690-6. PubMed ID: 15465888
[TBL] [Abstract][Full Text] [Related]
7. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency.
Maruyama Z; Yoshida CA; Furuichi T; Amizuka N; Ito M; Fukuyama R; Miyazaki T; Kitaura H; Nakamura K; Fujita T; Kanatani N; Moriishi T; Yamana K; Liu W; Kawaguchi H; Nakamura K; Komori T
Dev Dyn; 2007 Jul; 236(7):1876-90. PubMed ID: 17497678
[TBL] [Abstract][Full Text] [Related]
8. Role for beta1 integrins in cortical osteocytes during acute musculoskeletal disuse.
Phillips JA; Almeida EA; Hill EL; Aguirre JI; Rivera MF; Nachbandi I; Wronski TJ; van der Meulen MC; Globus RK
Matrix Biol; 2008 Sep; 27(7):609-18. PubMed ID: 18619537
[TBL] [Abstract][Full Text] [Related]
9. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
Wang L; Liu S; Quarles LD; Spurney RF
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin/NFAT signaling in osteoblasts regulates bone mass.
Winslow MM; Pan M; Starbuck M; Gallo EM; Deng L; Karsenty G; Crabtree GR
Dev Cell; 2006 Jun; 10(6):771-82. PubMed ID: 16740479
[TBL] [Abstract][Full Text] [Related]
11. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity.
Iwasaki R; Ninomiya K; Miyamoto K; Suzuki T; Sato Y; Kawana H; Nakagawa T; Suda T; Miyamoto T
Biochem Biophys Res Commun; 2008 Dec; 377(3):899-904. PubMed ID: 18952053
[TBL] [Abstract][Full Text] [Related]
12. The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells.
Boban I; Jacquin C; Prior K; Barisic-Dujmovic T; Maye P; Clark SH; Aguila HL
Bone; 2006 Dec; 39(6):1302-12. PubMed ID: 16938497
[TBL] [Abstract][Full Text] [Related]
13. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
14. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro.
Zhang W; Pantschenko AG; McCarthy MB; Gronowicz G
Calcif Tissue Int; 2007 Feb; 80(2):111-22. PubMed ID: 17308993
[TBL] [Abstract][Full Text] [Related]
15. Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.
Gazzerro E; Deregowski V; Stadmeyer L; Gale NW; Economides AN; Canalis E
Bone; 2006 Dec; 39(6):1252-60. PubMed ID: 16934545
[TBL] [Abstract][Full Text] [Related]
16. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
Buttgereit F; Zhou H; Kalak R; Gaber T; Spies CM; Huscher D; Straub RH; Modzelewski J; Dunstan CR; Seibel MJ
Arthritis Rheum; 2009 Jul; 60(7):1998-2007. PubMed ID: 19565501
[TBL] [Abstract][Full Text] [Related]
17. Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function.
Bentmann A; Kawelke N; Moss D; Zentgraf H; Bala Y; Berger I; Gasser JA; Nakchbandi IA
J Bone Miner Res; 2010 Apr; 25(4):706-15. PubMed ID: 19821765
[TBL] [Abstract][Full Text] [Related]
18. Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling.
Sher LB; Harrison JR; Adams DJ; Kream BE
Calcif Tissue Int; 2006 Aug; 79(2):118-25. PubMed ID: 16927049
[TBL] [Abstract][Full Text] [Related]
19. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass.
Filvaroff E; Erlebacher A; Ye J; Gitelman SE; Lotz J; Heillman M; Derynck R
Development; 1999 Oct; 126(19):4267-79. PubMed ID: 10477295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
